Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report

    October 2017 in “ Drug safety - case reports ”
    Abdel-Motaal Fouda, Anees M. Bazeed
    Studysummary In this case report, the authors describe a 38-year-old male who developed painless hematuria and hematospermia, likely of prostatic origin, associated with finasteride treatment for androgenic alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials The Journal of Sexual Medicine · 2016
    2. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-Analysis PubMed · 2015
    3. Finasteride and the Uncertainties of Establishing Harms JAMA Dermatology · 2015
    4. Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia Archives of Dermatology · 2010
    5. 5alpha-Reductase: History and Clinical Importance PubMed · 2004

    Related research 4

    1. Post-Finasteride Adverse Effects in Male Androgenic Alopecia: A Case Report of Vitiligo Skin Pharmacology and Physiology · 2017
    2. Sexual Adverse Effects of Finasteride 1mg for Treatment of Androgenic Alopecia in Men Scripta Scientifica Vox Studentium · 2017
    3. 5α-Reductase Inhibitors in Androgenetic Alopecia Current Opinion in Endocrinology, Diabetes and Obesity · 2014
    4. Comparison of Clinical Trials with Finasteride and Dutasteride PubMed · 2004